{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:49:52Z","timestamp":1778503792489,"version":"3.51.4"},"reference-count":87,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T00:00:00Z","timestamp":1237420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Lipoprotein (a) [Lp(a)] is a genetically determined molecule whose role has been implied in cardiovascular pathology, and whose levels have been reported to be elevated in patients with psoriasis.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To assess the serum levels of Lp(a) in patients with psoriasis, and to investigate the associations of Lp(a) with other lipids and with psoriasis severity.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Thirty\u2010four patients with psoriasis and 26 healthy control subjects took part in the study. Serum levels of Lp(a) and total, high density lipoprotein (HDL), low density lipoprotein (LDL), and very low density lipoprotein (VLDL) cholesterol fractions were measured in all participants. The levels of triglycerides and total cholesterol were measured using enzymatic colorimetric tests; HDL and LDL cholesterol concentrations were determined by precipitation methods; the VLDL concentration was calculated according to the formula: VLDL cholesterol\u00a0=\u00a0triglycerides\/5.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Patients with psoriasis showed significantly higher serum levels of Lp(a) relative to controls. Even when controlling for normolipidemic vs. hyperlipidemic status, abnormal levels of Lp(a) (&gt;\u00a030\u00a0mg\/dL) were observed significantly more often in patients than in controls. In both patients and controls, Lp(a) levels correlated positively with total and HDL cholesterol levels. In patients, Lp(a) levels correlated positively with psoriasis severity.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Lp(a) may be a factor contributing to an increased cardiovascular risk in patients with psoriasis. A pathogenetic link may exist between this lipoprotein and psoriatic pathophysiology.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2009.03994.x","type":"journal-article","created":{"date-parts":[[2009,3,20]],"date-time":"2009-03-20T15:20:18Z","timestamp":1237562418000},"page":"379-387","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity"],"prefix":"10.1111","volume":"48","author":[{"given":"Aldona","family":"Pietrzak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"K\u0105dzielewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Janowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Roli\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Krasowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gra\u017cyna","family":"Chodorowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Paszkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Kape\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Jastrz\u0119bska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Tabarkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torello","family":"Lotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,19]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1963.tb01808.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2530631"},{"key":"e_1_2_7_4_2","first-page":"69","article-title":"Lipoproteina(a) jako biochemiczny marker mia\u017cd\u017cycy naczy\u0144 wie\u0144cowych.","volume":"1","author":"Gancarz A.","year":"1996","journal-title":"Lek Wojsk"},{"key":"e_1_2_7_5_2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0190-9622(94)70208-X","article-title":"Are lipoprotein profile and lipoprotein(a) levels altered in men with psoriasis?","volume":"31","author":"Se\u00e7kin D","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_7_6_2","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1016\/S0021-9258(18)32663-2","article-title":"Human plasma lipoprotein[a]. Structural properties","volume":"258","author":"Gaubatz JW","year":"1983","journal-title":"J Biol Chem"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(83)80182-3"},{"key":"e_1_2_7_8_2","first-page":"142","article-title":"Lipoprotein(a): a genetically determined cardiovascular pathogen in search of a function","volume":"116","author":"Scanu AM","year":"1990","journal-title":"J Lab Clin Med"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1074\/jbc.272.17.11079","article-title":"Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase. Generation of mini\u2010lp(a) particles and apo(a) fragments","volume":"272","author":"Edelstein C","year":"1997","journal-title":"J Biol Chem"},{"key":"e_1_2_7_10_2","first-page":"48","article-title":"Recent advances in lipoprotein and atherosclerosis research at Baylor College of Medicine. Apolipoprotein B, lipoprotein(a), and transplantation arteriopathy","volume":"21","author":"Ballantyne CM","year":"1994","journal-title":"Text Heart Inst J"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(94)00737-3"},{"key":"e_1_2_7_12_2","first-page":"24","article-title":"Expression of human apolipoprotein B90 in transgenic mice: demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein(a)","volume":"269","author":"McCormick SPA","year":"1994","journal-title":"J Biol Chem"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.24.11643"},{"key":"e_1_2_7_14_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0021-9258(19)36587-1","article-title":"Identification of the cysteine residue in apolipoprotein B\u2010100","volume":"268","author":"Koschinsky ML","year":"1993","journal-title":"J Biol Chem"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2004.10.007"},{"key":"e_1_2_7_16_2","first-page":"672","article-title":"Lipoprotein(a): a unique risk factor for atherothrombotic disease","volume":"10","author":"Loscalzo J.","year":"1990","journal-title":"Atherosclerosis"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114625"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-3-209"},{"key":"e_1_2_7_19_2","first-page":"249","article-title":"Lipoprotein(a): structure, biology, and clinical relevance","volume":"36","author":"Scanu AM","year":"1991","journal-title":"Adv Intern Med"},{"key":"e_1_2_7_20_2","volume-title":"Patofizjologia","author":"Cybulska B","year":"2000"},{"key":"e_1_2_7_21_2","first-page":"323","article-title":"Lipoproteina(a) \u2013 budowa, w\u0142asciwosci, znaczenie fizjologiczne i patologiczne","volume":"57","author":"Murawska\u2010Cia\u0142owicz E","year":"2003","journal-title":"Post Hig Med Do\u015bw"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-3084(94)90157-0"},{"key":"e_1_2_7_23_2","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/clinchem\/44.8.1827","article-title":"Evolving lipoprotein risk factors: lipoprotein(a) and oxidized low density lipoprotein","volume":"44","author":"Jialal I.","year":"1998","journal-title":"Clin Chem"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005990050077"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(02)00373-X"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(03)00082-2"},{"key":"e_1_2_7_27_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2340\/00015555671215","article-title":"Serum lipoproteins in middle\u2010aged men with psoriasis","volume":"67","author":"Vahlquist C","year":"1987","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_7_28_2","first-page":"147","article-title":"Native plasma treatment of children with psoriasis","volume":"33","author":"Zo\u0142otuchina H.","year":"1970","journal-title":"Sov Med"},{"key":"e_1_2_7_29_2","first-page":"31","article-title":"Lipid metabolism in patients with changes in the osteoarticular apparatus in psoriasis","volume":"45","author":"Nesterenko GB","year":"1971","journal-title":"Vestn Dermatol Venereol"},{"key":"e_1_2_7_30_2","first-page":"15","article-title":"Relationship between certain indicators of lipid metabolism in the skin and blood in psoriasis","volume":"48","author":"Dow\u017ca\u0144ski SI","year":"1974","journal-title":"Vestn Dermatol Venereol"},{"key":"e_1_2_7_31_2","first-page":"460","article-title":"Metabolism pathology in psoriasis","volume":"160","author":"Dow\u017ca\u0144ski SI","year":"1974","journal-title":"Dermatol Monatsschr"},{"key":"e_1_2_7_32_2","first-page":"60","article-title":"Some indices of lipid metabolism in children suffering from psoriasis","volume":"6","author":"Panfi\u0142owa TS","year":"1983","journal-title":"Vestn Dermatol"},{"key":"e_1_2_7_33_2","first-page":"50","article-title":"Effect of hemosorption on the state of lipid metabolism in patients with psoriasis","volume":"59","author":"Lurie W\u0141","year":"1985","journal-title":"Vestn Dermatol Venereol"},{"key":"e_1_2_7_34_2","first-page":"10","article-title":"Study of lipoprotein blood spectrum in patients with disseminated psoriasis in the course of selective phototherapy","volume":"3","author":"Olisowa MO","year":"1985","journal-title":"Vestn Dermatol"},{"key":"e_1_2_7_35_2","first-page":"1023","article-title":"[Serum apolipoprotein levels in psoriatic patients]","volume":"100","author":"Imamura T","year":"1990","journal-title":"Nippon Hifuka Gakkai Zasshi"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2002.013"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcatb.2006.02.005"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247421"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(97)00072-7"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(00)00358-2"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2003.44.1.24"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:EJEP.0000020447.59150.f9"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.11.904"},{"key":"e_1_2_7_44_2","first-page":"128","article-title":"Cholesterol and lipoprotein(a) levels in psoriasis","volume":"88","author":"Stinson J","year":"1995","journal-title":"Ir Med J"},{"key":"e_1_2_7_45_2","first-page":"457","article-title":"Psoriasis and heart. Something new under the sun","volume":"141","author":"Pietrzak A","year":"2006","journal-title":"G Ital Dermatol Venereol"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2000.3070"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-4887.1997.tb01598.x"},{"key":"e_1_2_7_48_2","first-page":"CR493","article-title":"Sex\u2010specific associations of lipoprotein(a) with presence and quantity of coronary artery calcification in an asymptomatic population","volume":"10","author":"Cassidy AE","year":"2004","journal-title":"Med Sci Monit"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(81)90103-9"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03380180102027"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90520-W"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90862-F"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.301.6763.1248"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.17.5.942"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02246.x"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07562.x"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.446"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01499.x"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(97)00119-8"},{"issue":"4","key":"e_1_2_7_60_2","first-page":"51","article-title":"Cardiovascular risk among US psoriasis patients: evidence from two large healthcare databases","volume":"126","author":"Robinson D","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"4","key":"e_1_2_7_61_2","first-page":"47","article-title":"The increased risk of myocardial infarction in patients with psoriasis","volume":"126","author":"Gelfand JM","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"4","key":"e_1_2_7_62_2","first-page":"48","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis: a population\u2010based study using the General Practice Research Database","volume":"126","author":"Neimann AL","year":"2006","journal-title":"J Invest Dermatol"},{"key":"e_1_2_7_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.040"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079904X15192"},{"key":"e_1_2_7_65_2","first-page":"9","article-title":"Activity of serum lipase [EC 3.1.1.3] and the diversity of serum lipid profile in psoriasis","volume":"8","author":"Pietrzak A","year":"2002","journal-title":"Med Sci Monit"},{"key":"e_1_2_7_66_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1395.016"},{"key":"e_1_2_7_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22447"},{"key":"e_1_2_7_68_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb01773.x"},{"key":"e_1_2_7_69_2","first-page":"277","volume-title":"Psoriasis. Proceedings of the International Symposium","author":"Wilkinson DI","year":"1971"},{"key":"e_1_2_7_70_2","first-page":"40","article-title":"Phospholipid involvement in psoriatic epidermis","volume":"30","author":"Ansidei V","year":"1981","journal-title":"Ital J Biochem"},{"key":"e_1_2_7_71_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2004.19.6.859"},{"key":"e_1_2_7_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0906-6705.2004.00169.x"},{"key":"e_1_2_7_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/bip.1006"},{"key":"e_1_2_7_74_2","first-page":"255","article-title":"Hautkranheiten und cholesterinaemiae.","volume":"1","author":"Ishimaru H.","year":"1923","journal-title":"Acta Dermatol"},{"key":"e_1_2_7_75_2","first-page":"199","article-title":"High prevalence of cardiovascular diseases and enhanced activity of the renin\u2013angiotensin system in psoriatic patients","volume":"40","author":"Ena P","year":"1985","journal-title":"Acta Cardiol"},{"key":"e_1_2_7_76_2","first-page":"85","article-title":"Osservazioni sul metabolismo lipidico in soggetti affetti da psoriasi. Dati preliminari","volume":"122","author":"Barba A","year":"1987","journal-title":"G Ital Dermatol Venereol"},{"key":"e_1_2_7_77_2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2340\/0001555574176178","article-title":"Abnormalities of plasma lipoprotein composition and fluidity in psoriasis","volume":"74","author":"Ferretti G","year":"1994","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_7_78_2","first-page":"38","article-title":"Lipoprotein peroxidation in adult psoriatic patients.","volume":"186","author":"Offidani AM","year":"1994","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"e_1_2_7_79_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb03411.x"},{"key":"e_1_2_7_80_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1997.tb00211.x"},{"key":"e_1_2_7_81_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2003.00792_11.x"},{"key":"e_1_2_7_82_2","first-page":"A49","article-title":"Psoriasis is associated with dyslipoproteinemia already at the onset of skin disease","volume":"124","author":"Mallbris L","year":"2005","journal-title":"Invest Dermatol"},{"key":"e_1_2_7_83_2","first-page":"729","article-title":"Postheparin serum lipolytic activity in psoriatic males","volume":"6","author":"Pietrzak A","year":"2000","journal-title":"Med Sci Monit"},{"key":"e_1_2_7_84_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1966.36"},{"key":"e_1_2_7_85_2","first-page":"351","article-title":"Beitrage zur Atiologie und Pathogenese der Psoriasis vulgaris. [A contribution to the etiology and pathogenesis of psoriasis vulgaris]","volume":"9","author":"Melczer N","year":"1958","journal-title":"Hautarzt"},{"key":"e_1_2_7_86_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12542979"},{"key":"e_1_2_7_87_2","doi-asserted-by":"publisher","DOI":"10.2307\/3761291"},{"key":"e_1_2_7_88_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02748.x"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2009.03994.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2009.03994.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T18:14:55Z","timestamp":1696961695000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2009.03994.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,19]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1365-4632.2009.03994.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2009.03994.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,19]]},"assertion":[{"value":"2009-03-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}